Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at increasing the horizons of cytokine-based immunotherapy, especially for cancers where treatment choices remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline We https://financefeeds.com/shiba-inu-price-prediction-will-shib-continue-tumbling-in-2025-as-investors-turn-to-this-0-20-alternative/